{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:48:46Z","timestamp":1790516926768,"version":"4.1.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T00:00:00Z","timestamp":1512691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"name":"ERAnet","award":["FWF I656-B09"],"award-info":[{"award-number":["FWF I656-B09"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>No data are available on the in vivo impact of infections with in vitro azole-resistant Aspergillus fumigatus in immunocompetent hosts. Here, the aim was to investigate fungal fitness and treatment response in immunocompetent mice infected with A. fumigatus (parental strain [ps]) and isogenic mutants carrying either the mutation M220K or G54W (cyp51A). The efficacy of itraconazole (ITC) and posaconazole (PSC) was investigated in mice, intravenously challenged either with a single or a combination of ps and mutants (6 \u00d7 105 conidia\/mouse). Organ fungal burden and clinical parameters were measured. In coinfection models, no fitness advantage was observed for the ps strain when compared to the mutants (M220K and G54W) independent of the presence or absence of azole-treatment. For G54W, M220K, and the ps, no statistically significant difference in ITC and PSC treatment was observed in respect to fungal kidney burden. However, clinical parameters suggest that in particular the azole-resistant strain carrying the mutation G54W caused a more severe disease than the ps strain. Mice infected with G54W showed a significant decline in body weight and lymphocyte counts, while spleen\/body weight ratio and granulocyte counts were increased. In immunocompetent mice, in vitro azole-resistance did not translate into therapeutic failure by either ITC or PSC; the immune system appears to play the key role in clearing the infection.<\/jats:p>","DOI":"10.1093\/mmy\/myx109","type":"journal-article","created":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T11:08:28Z","timestamp":1507201708000},"page":"703-710","source":"Crossref","is-referenced-by-count":12,"title":["Azole-resistant and -susceptible Aspergillus fumigatus isolates show comparable fitness and azole treatment outcome in immunocompetent mice"],"prefix":"10.1093","volume":"56","author":[{"given":"Michaela","family":"Lackner","sequence":"first","affiliation":[{"name":"Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Rambach","sequence":"first","affiliation":[{"name":"Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emina","family":"Jukic","sequence":"first","affiliation":[{"name":"Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Sartori","sequence":"first","affiliation":[{"name":"Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Fritz","sequence":"first","affiliation":[{"name":"Department for Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Seger","sequence":"first","affiliation":[{"name":"Division of Mass Spectrometry and Chromatography, Institute of Medical and Chemical Laboratory Diagnostics (ZIMCL), University Hospital Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Hagleitner","sequence":"first","affiliation":[{"name":"Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Speth","sequence":"first","affiliation":[{"name":"Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Lass-Fl\u00f6rl","sequence":"first","affiliation":[{"name":"Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"2020041602155678800_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","article-title":"European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3\u20132009 update","volume":"46","author":"Maertens","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"2020041602155678800_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2020041602155678800_bib3","first-page":"605","article-title":"A consort analysis of randomised controlled trials for the treatment of invasive aspergillosis","volume":"55","author":"Jones","year":"2017","journal-title":"Med Mycol"},{"key":"2020041602155678800_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3201\/eid2201.150848","article-title":"Azole resistance of Aspergillus fumigatus in immunocompromised patients with invasive Aspergillosis.","volume":"22","author":"Alanio","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2020041602155678800_bib5","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2165\/00003495-200767110-00004","article-title":"Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients","volume":"67","author":"Maschmeyer","year":"2007","journal-title":"Drugs"},{"key":"2020041602155678800_bib6","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/AAC.00383-13","article-title":"Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study).","volume":"57","author":"Alastruey-Izquierdo","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2020041602155678800_bib7","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/JCM.00854-09","article-title":"Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the transplant-associated infection surveillance network","volume":"47","author":"Baddley","year":"2009","journal-title":"J Clin Microbiol"},{"key":"2020041602155678800_bib8","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1128\/AAC.02487-12","article-title":"Is azole resistance in Aspergillus fumigatus a problem in Spain?","volume":"57","author":"Escribano","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2020041602155678800_bib9","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1128\/AAC.00127-15","article-title":"First description of azole-resistant Aspergillus fumigatus due to TR46\/Y121F\/T289A mutation in France.","volume":"59","author":"Lavergne","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2020041602155678800_bib10","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1128\/AAC.01092-06","article-title":"A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations","volume":"51","author":"Mellado","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2020041602155678800_bib11","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/jac\/dku566","article-title":"Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.","volume":"70","author":"Steinmann","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2020041602155678800_bib12","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2217\/fmb.11.118","article-title":"Azole resistance in Aspergillus: a growing public health menace","volume":"6","author":"Denning","year":"2011","journal-title":"Future Microbiol"},{"key":"2020041602155678800_bib13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in Aspergillus fumigatus: Can we retain the clinical use of mold-active antifungal azoles?","volume":"62","author":"Verweij","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020041602155678800_bib14","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/AAC.48.7.2747-2750.2004","article-title":"Substitutions at methionine 220 in the 14alpha-sterol demethylase (cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs","volume":"48","author":"Mellado","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2020041602155678800_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/dkh507","article-title":"Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma","volume":"55","author":"Chen","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"2020041602155678800_bib16","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1128\/AAC.48.11.4405-4413.2004","article-title":"In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance","volume":"48","author":"da Silva Ferreira","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2020041602155678800_bib17","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1128\/AAC.47.3.1120-1124.2003","article-title":"A point mutation in the 14alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus","volume":"47","author":"Diaz-Guerra","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2020041602155678800_bib18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.47.2.577-581.2003","article-title":"Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase.","volume":"47","author":"Mann","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2020041602155678800_bib19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/JCM.43.1.214-222.2005","article-title":"Rapid, high-throughput, multiplex, real-time PCR for identification of mutations in the cyp51A gene of Aspergillus fumigatus that confer resistance to itraconazole","volume":"43","author":"Balashov","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2020041602155678800_bib20","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1128\/AAC.47.5.1719-1726.2003","article-title":"Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole","volume":"47","author":"Nascimento","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2020041602155678800_bib21","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"2020041602155678800_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jgar.2015.01.005","article-title":"Triazole-resistant Aspergillus fumigatus harbouring G54 mutation: is it de novo or environmentally acquired?","volume":"3","author":"Sharma","year":"2015","journal-title":"J Glob Antimicrob Resist"},{"key":"2020041602155678800_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jocn.2016.02.026","article-title":"Management of post-haemorrhagic hydrocephalus in premature infants","volume":"31","author":"Ellenbogen","year":"2016","journal-title":"J Clin Neurosci"},{"key":"2020041602155678800_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7984032","article-title":"Invasive pulmonary aspergillosis with disseminated infection in immunocompetent patient","author":"Moreno-Gonz\u00e1lez","year":"2016","journal-title":"Can Respir J"},{"key":"2020041602155678800_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajo.2016.03.007","article-title":"Isolated orbital aspergillosis in immunocompotent patients: A multicenter study","volume":"165","author":"Aggarwal","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"2020041602155678800_bib26","doi-asserted-by":"crossref","first-page":"E250","DOI":"10.21037\/jtd.2016.02.23","article-title":"Airway centered invasive pulmonary aspergillosis in an immunocompetent patient: case report and literature review","volume":"8","author":"Kim","year":"2016","journal-title":"J Thorac Dis"},{"key":"2020041602155678800_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.idc.2015.10.015","article-title":"Invasive aspergillosis: current strategies for diagnosis and management","volume":"30","author":"Cadena","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"2020041602155678800_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/postgradmedj-2014-206291rep","article-title":"Republished: The clinical spectrum of pulmonary aspergillosis","volume":"91","author":"Kosmidis","year":"2015","journal-title":"Postgrad Med J"},{"key":"2020041602155678800_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000449037","article-title":"Personalized medicine for chronic respiratory infectious diseases: tuberculosis, nontuberculous mycobacterial pulmonary diseases, and chronic pulmonary aspergillosis","volume":"92","author":"Salzer","year":"2016","journal-title":"Respiration"},{"key":"2020041602155678800_bib30","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1128\/EC.00171-13","article-title":"Contributions of Aspergillus fumigatus ATP-binding cassette transporter proteins to drug resistance and virulence","volume":"12","author":"Sanjoy","year":"2013","journal-title":"Eukaryot Cell"},{"key":"2020041602155678800_bib31","doi-asserted-by":"crossref","first-page":"e72280","DOI":"10.1371\/journal.pone.0072280","article-title":"Composite survival index to compare virulence changes in azole-resistant Aspergillus fumigatus clinical isolates","volume":"8","author":"Mavridou","year":"2013","journal-title":"PLoS One"},{"key":"2020041602155678800_bib32","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1128\/AAC.01594-15","article-title":"Fitness studies of azole-resistant strains of Aspergillus fumigatus","volume":"59","author":"Valsecchi","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2020041602155678800_bib33","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.00156-08","article-title":"Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus","volume":"52","author":"Rodriguez-Tudela","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2020041602155678800_bib34","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"2020041602155678800_bib35","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis."},{"key":"2020041602155678800_bib36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.riam.2016.04.001","article-title":"The role of epidemiological cutoff values (ECVs\/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds","volume":"33","author":"Espinel-Ingroff","year":"2016","journal-title":"Rev Iberoam Micol"},{"key":"2020041602155678800_bib37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.imbio.2010.04.007","article-title":"Differential mechanisms of resistance to sublethal systemic Aspergillus fumigatus infection in immunocompetent BALB\/c and C57BL\/6 mice","volume":"216","author":"Mirkov","year":"2011","journal-title":"Immunobiology"},{"key":"2020041602155678800_bib38","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1093\/nar\/20.22.6115","article-title":"A simple and efficient protocol for isolation of high molecular weight DNA from filamentous fungi, fruit bodies, and infected plant tissues","volume":"20","author":"M\u00f6ller","year":"1992","journal-title":"Nucleic Acids Res"},{"key":"2020041602155678800_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drup.2014.06.001","article-title":"The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside","volume":"17","author":"Seyedmousavi","year":"2014","journal-title":"Drug Resist Updat"},{"key":"2020041602155678800_bib40","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1517\/14656566.2015.1083976","article-title":"Treatment of drug-resistant Aspergillus infection","volume":"16","author":"Aigner","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"2020041602155678800_bib41","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1128\/AAC.00167-13","article-title":"cyp51A-based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany","volume":"57","author":"Bader","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2020041602155678800_bib42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijantimicag.2010.03.006","article-title":"A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease","volume":"36","author":"Olivieri","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"2020041602155678800_bib43","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nri1669","article-title":"Structure and function of the spleen","volume":"5","author":"Mebius","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"2020041602155678800_bib44","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","article-title":"Antifungal agents: mechanisms of action","volume":"11","author":"Odds","year":"2003","journal-title":"Trends Microbiol"},{"key":"2020041602155678800_bib45","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1128\/AAC.00931-09","article-title":"Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene","volume":"54","author":"Mavridou","year":"2010","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/56\/6\/703\/33046923\/myx109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/56\/6\/703\/33046923\/myx109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T06:17:31Z","timestamp":1587017851000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/56\/6\/703\/4714806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,12,8]]},"published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myx109","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8]]},"published":{"date-parts":[[2017,12,8]]}}}